Octagon Process LLC has been acquired by Clariant Corporation
Clariant Corporation, a Switzerland-headquartered global specialty chemical producer and distributor, has acquired Octagon Process LLC (Octagon), a leading supplier of de-icing chemicals for aircraft and runways, for an undisclosed consideration.
Octagon is a leading US manufacturer and supplier of specialty chemical fluids for the commercial, cargo and military aviation markets. Over the past 60 years, the company has evolved into a global leader in the development of cutting-edge and environmentally sensitive deicing and anti-icing fluids.
Clariant is a publicly traded global leader in the field of specialty chemicals. Strong business relationships, commitment to outstanding service and wide-ranging application know-how make Clariant a preferred partner for its customers.
Octagon and Clariant expect that the combination will enable enhanced product and service offerings and the logistical and sourcing strengths of a global organization.
One of Oaklins' teams in the USA advised the seller in this transaction.


Talk to the deal team
Jerome S. Romano
Oaklins TM Capital
Related deals
Largest AIM IPO in the business support services sector over the past five years has been completed
MHA plc raised US$131 million (£98 million) through a placing and retail offer, achieving a market capitalization of approximately US$363 million (£271 million) on admission. This was the largest AIM IPO in the business support services sector over the past five years. The IPO provides a platform for continued investment in technology, talent and acquisitions, supporting the group’s ambition to become a top 10 UK professional services firm.
Learn morePredatech Limited has been acquired by Ekco Group
UK-based cybersecurity consultancy Predatech Limited has been acquired by Ekco Group.
Learn moreManolete Partners plc has completed a successful debt refinancing
Manolete Partners plc has signed a new revolving credit facility (RCF) with its existing provider, HSBC. The new RCF provides Manolete with the same level of facility as the previous arrangement, at US$22.6 million (£17.5 million), but with a reduced margin and lower non-utilization fee. The facility has a term of 3.25 years, with the option to extend for an additional year on the same terms.
Learn more